PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
17-Feb-2023 U.S. FDA Accepts for Priority Review the Supplemental New Drug Application for Merck’s PREVYMIS™ for Prophylaxis of Cytomegalovirus Disease in Kidney Transplant Recipients at High Risk Businesswire
17-Feb-2023 Vitamin D Market Report 2022: Rising Number of Biofortification Innovation Hubs Boosts Growth - ResearchAndMarkets.com Businesswire
17-Feb-2023 Global Personalized Nutrition Market Report 2023 to 2028: Rising Technology Innovations and Advancements Presents Opportunities - ResearchAndMarkets.com Businesswire
17-Feb-2023 Project Management Virtual Bootcamp (March 22-23, 2023): Creating the Foundation for Project Management Success - ResearchAndMarkets.com Businesswire
17-Feb-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
17-Feb-2023 Colorado Governor Polis Helps Agilent Break Ground on $725 Million Expansion of Manufacturing Operations in Frederick Businesswire
17-Feb-2023 Canmart Ends CEO Service Agreement; Akanda Approves Appointment of Director Businesswire
17-Feb-2023 Aptar Reports Fourth Quarter and Annual 2022 Results Businesswire
17-Feb-2023 Stevanato Group to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 2, 2023 Businesswire
17-Feb-2023 Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2022 Financial Results Businesswire
17-Feb-2023 Cognex Announces Appointment of New Board Member and Retirement of Two Board Members Businesswire
17-Feb-2023 Fluor Selected for Agilent Life Sciences Facility Expansion in Colorado Businesswire
17-Feb-2023 Prothena to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023 Businesswire
17-Feb-2023 Bio-Rad Reports Fourth-Quarter and Full-Year 2022 Financial Results Businesswire
17-Feb-2023 Blue Earth Diagnostics Announces Additional Results from Phase 3 LIGHTHOUSE Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Newly Diagnosed Prostate Cancer Businesswire
16-Feb-2023 JVS Boston Names Kira Khazatsky as New CEO Businesswire
16-Feb-2023 New NUBEQA® (darolutamide) Subgroup Analyses from the Phase III ARASENS Trial in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Patients Presented at ASCO GU Businesswire
16-Feb-2023 Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Versus Chemotherapy Alone in Patients With HER2-Negative Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma Regardless of PD-L1 Expression Businesswire
16-Feb-2023 eClinical Solutions Celebrates Accelerated Growth, New Products, and Industry Awards in Milestone 10th Year of Business Businesswire
16-Feb-2023 Cure Rare Disease Receives Muscular Dystrophy Association Grant Businesswire